Sign in
Enrolling by invitationNo phase

Following young adults with and without very flexible joints over time

Follows health science students with and without joint hypermobility to see who develops symptoms.

Key facts

Who runs it
Clarkson University
Where
Potsdam, United StatesSee the site
Trial code
Registry title
Presentation of Young Adults With and Without Joint Hypermobility
Status
Enrolling by invitation
People taking part
100 people, planned
Started
23 Sept 2026
Expected to end
20 Jun 2036
Type of study
Observational, 3 groups
Record updated
22 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for Clarkson University Health Sciences students, with or without very flexible (hypermobile) joints. It will follow them over time to study symptoms.

Age
18 Years to 60 Years
Sex
All sexes can join.
Disease stage
People with hEDS or HSD, people with very flexible joints but no symptoms, and people without very flexible joints can join.

Main reasons for not taking part

  • Other physical conditions that prevent collecting more than 25% of the physical measurements at the first visit

The registry criteria, word for word

Show the criterionShow less

Who cannot take part

  • -

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

  • Clarkson University, Lewis School of Health & Life SciencesPotsdam, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

People with multiple hypermobile joints are diagnosed with Generalized Joint Hypermobility (GJH) when asymptomatic, or Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD) when symptomatic (hEDS/HSD, or 'HSD' here). GJH likely affects about 20% of the U.S. population, while HSD affects 0.5-3% of the US population. Although joint hypermobility is the most visible presentation of HSD, it is a systemic connective tissue disorder affecting multiple body systems. Due to frequent health concerns, HSD may contribute to more than 30% of patients in chronic pain, rheumatology, orthopedic and physical therapy clinics. It is still unclear why some people have asymptomatic hypermobility and others develop complex chronic health issues. However, recent research suggests that the transition might be triggered by severe physiological stress, such as viral infection.

Read full original descriptionShow less

HSD is commonly associated with Postural Orthostatic Tachycardia Syndrome (POTS) and Mast Cell Activation Syndrome (MCAS), as well as gastrointestinal (GI) problems. Recent research suggests that persistent inflammation due to MCAS or COVID may trigger HSD symptoms. The correlation between POTS and HSD may be due to effects of HSD on the autonomic nervous system or to inflammation triggering both conditions. It is also unclear whether body awareness and coordination deficits seen in symptomatic HSD are due to the fundamental connective tissue disorder or due to pain and injuries in HSD. This study seeks to determine whether asymptomatic hypermobile individuals (GJH) also have balance and coordination deficits. The current study hopes to identify factors that correlate with a transition from asymptomatic GJH to symptomatic HSD by following a group of Health Science students forward in time. The study will collect baseline health information including relevant diagnoses, symptoms and function. Physical measurements will include standard clinical tests performed by physical therapists: joint hypermobility and instability, standing balance, neck movement control, and heart rate in response to standing from lying down. The study is likely to last for at least 10 years to follow participants over time.

The 3 groups in the trial

  • hypermobile - symptomatic

    People who meet the diagnostic criteria for hEDS or HSD

  • non-hypermobile

    People who do not meet the diagnostic criteria for generalized joint laxity, hEDS or HSD

  • hypermobile - non-symptomatic

    People with generalized joint laxity but not meeting diagnostic criteria for hEDS/HSD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective Study of Symptoms in People With and Without Joint Hypermobility
Plain-language title
Following young adults with and without very flexible joints over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07657507, who can take part
Record updated
22 October 2026